MedTech Pulse’s Post

The SaaS industry is revolutionizing the medical field! At RevTek Capital, we’re witnessing how innovative software solutions enhance patient care, streamline operations, and drive medical advancements. From telehealth platforms to advanced data analytics, SaaS is improving healthcare. Let's explore the future of health tech together in the Recap of the MedCity News Invest Healthcare Conference! 🚀💼 #SaaS #HealthTech #Innovation #RevTekCapital

India’s HealthTech sector is rapidly evolving, driven by innovative startups leveraging technology to improve healthcare access, quality, and affordability. Here, we highlight ten standout HealthTech startups making significant strides in transforming the Indian healthcare landscape. https://lnkd.in/dWdn4zSH

Today's news that Dexcom, which makes medical devices, is partnering with, and investing $75m in smart ring company, ŌURA, is a harbinger of things to come in healthcare. Dexcom developed a popular glucose monitoring system that helps people with diabetes manage their condition. As part of the tie-up with Oura, the companies will make it easier for users to improve their metabolic health through the integration of Dexcom glucose data with sleep, stress, heart health and activity data from Oura. The deal also values Oura at more than $5b. Oura has quietly announced acquisitions and partnerships in the past few months to build a prolific metabolic health platform. In 2025, we'll see more partnerships like this where established healthcare companies partner with rapidly growing health technology companies. At Jarrard Inc., we've built a bridge between those two constituencies and are excited about partnering with both as they rapidly advance healthcare forward. 🩺 💉 💪 💍 https://lnkd.in/eBx8bza6

🔝 Top Players: Most Active Medical Device Companies in Digital Health 🔝 In the rapidly evolving landscape of #DigitalHealth, certain #medicaldevice (#MedDev) companies are leading the charge through strategic #partnerships. According to the latest Galen Growth | Insights You Can Trust research, powered by #HealthTechAlpha, seven MedDev companies have distinguished themselves by announcing ten or more new partnerships with Digital Health #ventures between January 2019 and September 2024. These partnerships highlight the commitment of these industry leaders to #innovate and integrate cutting-edge #technologies, enhancing #patientcare and advancing #healthcare solutions. By #collaborating with dynamic Digital Health #startups, these companies are leveraging advancements in areas such as #telemedicine, #remotemonitoring, #dataanalytics, and #AI-driven #diagnostics. This #trend not only underscores the pivotal role of #collaboration in driving technological progress but also demonstrates the #strategic importance of Digital Health in the #future of medical devices. Top players include: Siemens Healthineers GE HealthCare Dexcom Johnson & Johnson Philips Medtronic Illumina

🔥 The Q1 2024 MedTech in Numbers financial report is here! After hearing from our readers on how valuable the insights we provided in our 2023 financial report was, we decided to create a report to capture the health in the MedTech market in Q1 2024 and what it means for service providers. Special thanks to Weronika Michaluk, DrPH, MBA, Alex Condon, Duane Mancini, M. Sc., and a few others for their feedback from the last report. We added a new section that breaks down the therapeutic area by funding and medical technology type to provide more granularity. ⚡ As always Zapyrus customers will be able to click on those ZAP links that will take you to the exact companies and contacts that you'll need to action on this report. We love hearing from you so like, comment, and share to support us in creating more content for you. #medtech #businessdevelopment #sales #medicaldevice #diagnostic #IVD #saMD #financials #Q12024 https://lnkd.in/g56TmqPy

Great news on Q1 ‘24 MedTech Funding! “Financially, the funding climate in MedTech has increased by a significant amount in 2024 to date. In 2023, the entire year funding total was captured in our annual MedTech funding report and equated to $17.95 billion dollars of investments. The shocking low funding total was the result of the COVID-19 pandemic surge of funding in the peak pandemic years of 2021 - 2022 followed by the drastic dip in the following 2023 year, known as the “COVID Cliff”. This total made up approximately 11% of the MedTech market in reference to the number of MedTech companies. In contrast to last year, Q1 2024 alone saw a total of $11.04 billion dollars worth of investments received by MedTech companies around the globe excluding revenue dollars. The numbers suggest that the market is picking back up in a big way. However, looking at the M&A volume and clinical pipeline numbers between Q1 2023 and Q1 2024, we can have a more accurate look at how funding is a lagging indicator to how a market will perform in the current year.” MedTech Innovator MedTech World LSI MedTech Strategist MedTech Startup

🚀 Medtech soared in Q3 2024 with transformative M&A deals and innovation-driven venture funding. From advanced diagnostics to cutting-edge patient care, the sector's momentum shows no signs of slowing! 💡 📊 Check out the highlights of MedTech market activity in the attachments below! Contributors - Iyappan Annamalai Subbiah Malvika Verma Miller, Ph.D. #Medtech #Innovation #Healthcare #MADeals #VentureFunding #Q32024

🌟 Big News in Healthtech 🌟 I'm pleased to share that Doccla, a leading "Hospital at Home" startup, has just raised $46 million in Series B funding led by Lakestar, with support from Elaia and other existing investors. Doccla is revolutionizing healthcare with its innovative "virtual bed" technology, enabling doctors to remotely monitor patients who are discharged early or avoid hospital admission altogether. This approach not only alleviates pressure on overcrowded hospitals but also enhances patient care and convenience. Since its inception during the Covid-19 pandemic, Doccla has been making waves across the U.K. and Ireland, partnering with key healthcare providers like the NHS and Ireland’s Health Service Executive. Now, with this new funding, they’re set to expand their reach across Europe, bringing their cutting-edge technology to markets like Germany, Austria, and France. What sets Doccla apart? Their platform is device-agnostic, meaning it can integrate with a variety of monitoring devices, making it incredibly versatile. Plus, their user-friendly app connects patients and clinicians seamlessly through messaging and video calls, ensuring continuous care, even outside of regular hours. Beyond patient monitoring, Doccla is also making strides in the pharmaceutical industry, supporting virtual clinical trials. Their technology is helping to speed up drug research by reducing the need for in-person visits, making trials faster, more efficient, and more cost-effective. This is a significant step forward for healthcare innovation, and I’m excited to see how Doccla continues to reshape the future of patient care in Europe and beyond. #HealthTech #Innovation #DigitalHealth #Telemedicine #PatientCare #StartupGrowth #HealthcareRevolution #VirtualCare #EuropeExpansion

How are life sciences companies evolving to meet consumers where they are and drive adoption? And how do telehealth programs fit into these new models? Check out our latest white paper to explore how pharma companies are engaging patients in innovative ways. https://lnkd.in/gXEqbChr Key Topics: 🔸 Life sciences market dynamics in 2024 🔸Emerging DTC models for pharma 🔸An overview of current in-market virtual care programs 🔸A benefit analysis of virtual care for life sciences including key challenges and considerations 👉 Download this free white paper today! #lifesciences #pharma #whitepaper #consumerhealth #virtualcare #telehealth

📈 Medical Device Companies are Strengthening Their Ties with Digital Health Ventures Galen Growth | Insights You Can Trust has identified over 280 #medicaldevice companies (#medtech) actively #partnering with #DigitalHealth ventures, marking an impressive 1.8x increase in these #collaborations from 2020 to 2023. Despite this #growth, the #share of medical device #partnerships within the broader #landscape of #industry verticals engaging with Digital Health has remained relatively small, consistently between 3% and 4%. Notably, the #US is leading the way, with 58% of these partnerships involving #ventures based in the region. This #trend underscores the #strategic focus on #innovation #hubs where digital health #solutions are flourishing. These partnerships are pivotal, bringing together the expertise of medical device #manufacturers with the innovative capabilities of digital health #startups. By embracing these collaborations, medical device companies are advancing their #technological capabilities, enhancing #patientcare, and preparing for the future of #healthcare.